Market heavyweight drags NZX 50 down

Market heavyweight drags NZX 50 down
Fisher and Paykel Healthcare slipped and took the NZ sharemarket with it. (Image: Fisher and Paykel)
Graham Skellern
The weight of expectation pushed Fisher and Paykel Healthcare down more than 6% on the New Zealand sharemarket, which finished the week with a sharp 1% fall.Led by market leader Fisher and Paykel Healthcare, the S&P/NZX 50 Index was down 129.82 points or 1.09% to 11,830.03 and fell 2.5% for the week. The index is still ahead 3% so far this year and up about 6.5% over the past 12 months.There were 52 gainers and 74 decliners on the main board with 32.94 million shares worth $159.17m changing hands.Respiratory devices manufacturer Fisher...

More Markets

Pacific Edge 'star of the day' on NZX
Markets Market Close

Pacific Edge 'star of the day' on NZX

The S&P/NZX 50 Index closed up 0.17% or 22.50 points.

US CMS recommends 30% increase for Pacific Edge's Cxbladder Triage Plus price
Markets

US CMS recommends 30% increase for Pacific Edge's Cxbladder Triage Plus price

Cancer diagnostics company Pacific Edge has announced that the United States' Centers for Medicare & Medicaid Services (CMS) recommended a final “gapfill” price for its Cxbladder Triage Plus.CMS is proposing a price of US$1,328.32 (NZ$2,241.71), which is about 30% higher than...

Briscoe's bottom line squeezed despite flat first-half sales
Retail

Briscoe's bottom line squeezed despite flat first-half sales

Rod Duke expects full-year profits to come in lower than previously signalled.

ANZ's NZ operation may escape worst of 'Nuno-geddon'
Finance

ANZ's NZ operation may escape worst of 'Nuno-geddon'

ANZ NZ’s performance might be its potential saving grace.